Biontech Se ADR (BNTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BNTX | ALNY | BIIB | ||
| Company | Biontech Se ADR | Alnylam Pharmaceuticals | Biogen Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 108.85 | 268.47 | 172.71 | ||
| High | 111.25 | 268.89 | 177.25 | ||
| Low | 108.35 | 264.23 | 170.72 | ||
| Last | 110.90 | 265.45 | 176.83 | ||
| Change | +1.93 | -4.50 | +3.31 | ||
| % Change | +1.77% | -1.67% | +1.91% | ||
| Volume | 280,153 | 575,731 | 1,842,404 | ||
| 20-Day Average Volume | 650,505 | 854,035 | 1,371,501 | ||
| Previous Close | 108.97 | 269.95 | 173.52 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 113.97 | 284.45 | 184.03 | ||
| 20-Day Raw Stochastic | 25.94% | 5.13% | 22.57% | ||
| 20-Day Relative Strength | 49.76% | 43.37% | 35.74% | ||
| Weighted Alpha | -0.01 | +37.11 | -26.55 | ||
| Today's Opinion | 72% Buy | 56% Buy | 100% Sell | ||
| Previous Opinion | 56% Buy | 64% Buy | 100% Sell | ||
| Last Month's Opinion | 88% Buy | 80% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.71% since 10/29/24 | -6.66% since 10/29/24 | -4.07% since 10/29/24 | ||
| Low | 107.19 on 11/04/24 | 263.65 on 10/31/24 | 170.71 on 11/04/24 | ||
| High | 114.57 on 10/30/24 | 287.87 on 10/30/24 | 185.00 on 10/30/24 | ||
| 1-Month | |||||
| %Chg | -9.59% since 10/04/24 | -0.84% since 10/04/24 | -5.22% since 10/04/24 | ||
| Low | 107.19 on 11/04/24 | 263.65 on 10/31/24 | 170.71 on 11/04/24 | ||
| High | 124.00 on 10/07/24 | 304.39 on 10/17/24 | 194.13 on 10/15/24 | ||
| 3-Month | |||||
| %Chg | +41.55% since 08/05/24 | +0.28% since 08/05/24 | -11.29% since 08/05/24 | ||
| Low | 76.84 on 08/06/24 | 244.88 on 09/06/24 | 170.71 on 11/04/24 | ||
| High | 131.49 on 09/17/24 | 304.39 on 10/17/24 | 207.59 on 08/21/24 | ||
| 6-Month | |||||
| %Chg | +19.63% since 05/03/24 | +74.45% since 05/03/24 | -19.09% since 05/03/24 | ||
| Low | 76.53 on 08/05/24 | 144.73 on 05/16/24 | 170.71 on 11/04/24 | ||
| High | 131.49 on 09/17/24 | 304.39 on 10/17/24 | 238.00 on 07/12/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 25,909,362 | 34,818,424 | 25,285,160 | ||
| Shares Outstanding, K | 237,766 | 128,981 | 145,719 | ||
| Annual Sales | 4,133,300,000 | 1,828,290,000 | 9,835,600,000 | ||
| Annual Net Income | 1,006,860,000 | -440,240,000 | 1,161,100,000 | ||
| Last Quarter Sales | 138,600,000 | 500,920,000 | 2,465,800,000 | ||
| Last Quarter Net Income | -869,920,000 | -111,570,000 | 388,500,000 | ||
| 60-Month Beta | 0.26 | 0.39 | -0.06 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.81 on 11/04/24 | -0.50 on 10/31/24 | 4.08 on 10/30/24 | ||
| Latest Earnings Date | 11/04/24 | 10/31/24 | 10/30/24 | ||
| Most Recent Dividend | 3.084 on 06/02/22 | N/A | N/A | ||
| Next Ex-Dividends Date | 06/02/22 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 10.88 | ||